humulene has been researched along with Blepharoptosis* in 2 studies
1 review(s) available for humulene and Blepharoptosis
| Article | Year |
|---|---|
Association between cannabis and the eyelids: A comprehensive review.
Cannabis is the most consumed illicit drug worldwide. As more countries consider bills that would legalize adult use of cannabis, health care providers, including eye care professionals (ophthalmologists, optometrists), will need to recognize ocular effects of cannabis consumption in patients. There are only 20 studies on the eyelid effects of cannabis usage as a medical treatment or a recreational drug. These include ptosis induction, an "eyelid tremor" appearance and blepharospasm attenuation. Six articles describe how adequately dosed cannabis regimens could be promising medical treatments for blepharospasm induced by psychogenic factors. Fourteen articles report eyelid tremors in intoxicated drivers and ptosis as a secondary effect in cannabinoid animal experimental models. The exact mechanism of cannabinoids connecting cannabis to the eyelids is unclear. Further studies should be conducted to better understand the cannabinoid system in relation to the eyelid and eventually develop new, effective and safe therapeutic targets derived from cannabis. Topics: Animals; Blepharoptosis; Blepharospasm; Cannabinoids; Cannabis; Eyelids; Humans | 2020 |
1 other study(ies) available for humulene and Blepharoptosis
| Article | Year |
|---|---|
Chemical basis of hashish activity.
A sample of hashish was extracted consecutively with petroleum ether, benzene, and methanol. When tested intravenously in monkeys only the petroleum-ether fraction was active. This material was further fractionated. The only active compound isolated was Delta(1)-tetrahydrocannabinol. Cannabinol, cannabidiol, cannabichromene, cannabigerol, and cannabicyclol when administered together with Delta(1)-tetrahydrocannabinol do not cause a change in the activity of the latter, under the experimental conditions used. These results provide evidence that, except for Delta(1)-tetrahydrocannabinol, no other major, psychotomimetically active compounds are present in hashish. Topics: Animals; Behavior, Animal; Benzene; Benzopyrans; Blepharoptosis; Bridged-Ring Compounds; Cannabis; Chemistry, Pharmaceutical; Chloroform; Chromatography, Gas; Conjunctivitis; Consciousness; Haplorhini; Methanol; Movement; Petroleum; Phenols; Plant Extracts | 1970 |